Natera, Inc. (NASDAQ:NTRA – Get Ranking) CEO Steven Leonard Chapman offered 13,474 shares of Natera inventory in a transaction that occurred on Tuesday, February twenty eighth. The inventory was offered at a mean worth of $48.94, for a complete worth of $659,417.56. Following the transaction, the chief government officer now owns 245,963 shares of the corporate’s inventory, valued at $12,037,429.22. The sale was disclosed in a authorized submitting with the SEC, which is out there on the SEC web site.
Steven Leonard Chapman additionally just lately made the next commerce(s):
- On Monday, January twenty third, Steven Leonard Chapman offered 5,370 shares of Natera inventory. The inventory was offered at a mean worth of $41.56, for a complete worth of $223,177.20.
- On Tuesday, January third, Steven Leonard Chapman offered 8,212 shares of Natera inventory. The inventory was offered at a mean worth of $39.55, for a complete worth of $324,784.60.
- On Wednesday, December twenty eighth, Steven Leonard Chapman offered 2,605 shares of Natera inventory. The inventory was offered at a mean worth of $39.84, for a complete worth of $103,783.20.
- On Friday, December twenty third, Steven Leonard Chapman offered 1,660 shares of Natera inventory. The inventory was offered at a mean worth of $42.30, for a complete worth of $70,218.00.
- On Wednesday, December seventh, Steven Leonard Chapman offered 2,645 shares of Natera inventory. The inventory was offered at a mean worth of $38.31, for a complete worth of $101,329.95.
Natera Inventory Efficiency
NASDAQ:NTRA opened at $56.47 on Friday. The inventory has a fifty day shifting common worth of $43.10 and a 200-day shifting common worth of $43.80. The corporate has a market cap of $5.51 billion, a price-to-earnings ratio of -10.14 and a beta of 1.20. The corporate has a debt-to-equity ratio of 0.78, a fast ratio of two.95 and a present ratio of three.10. Natera, Inc. has a fifty-two week low of $26.10 and a fifty-two week excessive of $63.65.
Natera (NASDAQ:NTRA – Get Ranking) final launched its earnings outcomes on Tuesday, February twenty eighth. The medical analysis firm reported ($1.37) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.40) by $0.03. The agency had income of $217.30 million in the course of the quarter, in comparison with the consensus estimate of $215.50 million. Natera had a adverse return on fairness of 121.87% and a adverse web margin of 66.79%. The corporate’s income was up 25.6% in comparison with the identical quarter final yr. Throughout the identical interval within the prior yr, the corporate posted ($1.48) EPS. As a bunch, equities analysts anticipate that Natera, Inc. will publish -4.52 EPS for the present fiscal yr.
Hedge Funds Weigh In On Natera
Numerous institutional traders have just lately modified their holdings of NTRA. Financial institution of New York Mellon Corp raised its holdings in shares of Natera by 6.7% in the course of the 1st quarter. Financial institution of New York Mellon Corp now owns 820,974 shares of the medical analysis firm’s inventory value $33,399,000 after shopping for a further 51,791 shares within the final quarter. US Bancorp DE raised its holdings in shares of Natera by 20.0% in the course of the 1st quarter. US Bancorp DE now owns 16,180 shares of the medical analysis firm’s inventory value $658,000 after shopping for a further 2,698 shares within the final quarter. PNC Monetary Companies Group Inc. raised its holdings in shares of Natera by 215.2% in the course of the 1st quarter. PNC Monetary Companies Group Inc. now owns 2,049 shares of the medical analysis firm’s inventory value $83,000 after shopping for a further 1,399 shares within the final quarter. Financial institution of Montreal Can raised its holdings in shares of Natera by 80.6% in the course of the 1st quarter. Financial institution of Montreal Can now owns 130,062 shares of the medical analysis firm’s inventory value $5,390,000 after shopping for a further 58,049 shares within the final quarter. Lastly, MetLife Funding Administration LLC acquired a brand new place in shares of Natera in the course of the 1st quarter value $209,000. Institutional traders and hedge funds personal 93.81% of the corporate’s inventory.
Analysts Set New Worth Targets
A number of analysts just lately issued stories on the corporate. Stephens lowered their worth goal on Natera to $67.00 in a analysis notice on Wednesday, November sixteenth. Raymond James upgraded Natera from a “market carry out” ranking to an “outperform” ranking and set a $58.00 worth goal for the corporate in a analysis notice on Wednesday, January 18th. Credit score Suisse Group boosted their worth goal on Natera from $55.00 to $65.00 and gave the corporate an “outperform” ranking in a analysis notice on Wednesday. Piper Sandler boosted their worth goal on Natera from $70.00 to $80.00 in a analysis notice on Friday, February seventeenth. Lastly, BTIG Analysis lowered their worth goal on Natera from $95.00 to $75.00 in a analysis notice on Wednesday, November ninth. One equities analysis analyst has rated the inventory with a promote ranking and 6 have assigned a purchase ranking to the corporate’s inventory. Primarily based on information from MarketBeat.com, the corporate at the moment has a consensus ranking of “Reasonable Purchase” and a consensus goal worth of $78.36.
About Natera
(Get Ranking)
Natera, Inc is a diagnostics firm, which engages within the discovery, growth, and commercialization of genetic testing providers. It offers Panorama non-invasive prenatal check (NIPT), Vistara, horizon provider screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic analysis, Anora merchandise of conception (POC) and non-invasive paternity testing (PAT).
Advisable Tales
Obtain Information & Scores for Natera Every day – Enter your electronic mail deal with under to obtain a concise day by day abstract of the most recent information and analysts’ rankings for Natera and associated firms with MarketBeat.com’s FREE day by day electronic mail publication.
